# Largest biotech by market cap (2026)

URL: https://funkfolio.com/companies/category/biotech

> 24 US-listed biotech ranked by market value, led by Amgen ($247.7B), Gilead Sciences ($211.2B) and Moderna ($83.7B). Updated through the trading day.

---

## Largest biotech by market cap

Amgen leads the 24 biotech ranked by market value, at $247.7B, ahead of Gilead Sciences ($211.2B) and Moderna ($83.7B). Figures as of 18 Nov 2026, 09:32 UTC, from Yahoo Finance quotes.

### Key facts

- **Companies ranked:** 24
- **First:** Amgen $247.7B
- **Median:** $10.4B
- **Combined market value:** $848.9B
- **Countries:** 5

Market values as of 18 Nov 2026, 09:32 UTC.

[Clear filters](https://funkfolio.com/companies)

Largest biotech by market cap

| # | Company | Market cap ↓ | Price | Today | 1 year | Price, 30 days | Country |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1 | [Amgen AMGN · Health Care](https://funkfolio.com/stock/AMGN) | $247.7B | $457.93 | 0.95% down | 34% up | Price over the last month: up 7.8% | [United States](https://funkfolio.com/companies/country/united-states) |
| 2 | [Gilead Sciences GILD · Health Care](https://funkfolio.com/stock/GILD) | $211.2B | $170.26 | 1.60% up | 32% up | Price over the last month: up 11.2% | [United States](https://funkfolio.com/companies/country/united-states) |
| 3 | [Moderna MRNA · Health Care](https://funkfolio.com/stock/MRNA) | $83.7B | $206.80 | 3.93% down | 764% up | Price over the last month: down 8.9% | [United States](https://funkfolio.com/companies/country/united-states) |
| 4 | [argenx ARGX · Health Care](https://funkfolio.com/stock/ARGX) | $59.6B | $947.52 | 0.36% down | 4% up | Price over the last month: up 14.8% | [Belgium](https://funkfolio.com/companies/country/belgium) |
| 5 | [Biogen BIIB · Health Care](https://funkfolio.com/stock/BIIB) | $37.1B | $250.79 | 0.34% down | 49% up | Price over the last month: up 7.4% | [United States](https://funkfolio.com/companies/country/united-states) |
| 6 | [Revolution Medicines RVMD · Health Care](https://funkfolio.com/stock/RVMD) | $35.2B | $162.69 | 2.50% down | 136% up | Price over the last month: down 10.7% | [United States](https://funkfolio.com/companies/country/united-states) |
| 7 | [BioNTech BNTX · Health Care](https://funkfolio.com/stock/BNTX) | $21B | $84.86 | 0.47% down | 17% down | Price over the last month: down 4.9% | [Germany](https://funkfolio.com/companies/country/germany) |
| 8 | [Neurocrine Biosciences NBIX · Health Care](https://funkfolio.com/stock/NBIX) | $16.8B | $165.92 | 0.37% up | 19% up | Price over the last month: up 21.1% | [United States](https://funkfolio.com/companies/country/united-states) |
| 9 | [Exelixis EXEL · Health Care](https://funkfolio.com/stock/EXEL) | $16.7B | $68.50 | 2.09% up | 57% up | Price over the last month: up 9.3% | [United States](https://funkfolio.com/companies/country/united-states) |
| 10 | [Bio-Techne TECH · Health Care](https://funkfolio.com/stock/TECH) | $11.4B | $72.63 | 0.22% down | 25% up | Price over the last month: up 0.2% | [United States](https://funkfolio.com/companies/country/united-states) |
| 11 | [Halozyme Therapeutics HALO · Health Care](https://funkfolio.com/stock/HALO) | $10.9B | $95.97 | 0.55% down | 38% up | Price over the last month: down 21.7% | [United States](https://funkfolio.com/companies/country/united-states) |
| 12 | [Kymera Therapeutics KYMR · Health Care](https://funkfolio.com/stock/KYMR) | $10.4B | $121.52 | 3.44% down | 96% up | Price over the last month: up 12.4% | [United States](https://funkfolio.com/companies/country/united-states) |
| 13 | [Repligen RGEN · Health Care](https://funkfolio.com/stock/RGEN) | $10.4B | $162.18 | 0.37% down | 6% up | Price over the last month: down 8.1% | [United States](https://funkfolio.com/companies/country/united-states) |
| 14 | [Qiagen QGEN · Health Care](https://funkfolio.com/stock/QGEN) | $10.3B | $49.75 | 0.12% down | 12% up | Price over the last month: up 6.9% | [Netherlands](https://funkfolio.com/companies/country/netherlands) |
| 15 | [Vaxcyte PCVX · Health Care](https://funkfolio.com/stock/PCVX) | $9.4B | $59.40 | 3.59% down | 24% up | Price over the last month: down 6.7% | [United States](https://funkfolio.com/companies/country/united-states) |
| 16 | [Krystal Biotech KRYS · Health Care](https://funkfolio.com/stock/KRYS) | $8.8B | $298.55 | 0.22% up | 46% up | Price over the last month: down 6.8% | [United States](https://funkfolio.com/companies/country/united-states) |
| 17 | [Twist Bioscience TWST · Health Care](https://funkfolio.com/stock/TWST) | $7.4B | $112.00 | 6.63% up | 304% up | Price over the last month: down 19.9% | [United States](https://funkfolio.com/companies/country/united-states) |
| 18 | [CG Oncology CGON · Health Care](https://funkfolio.com/stock/CGON) | $7.1B | $78.94 | 6.89% down | 99% up | Price over the last month: up 31.7% | [United States](https://funkfolio.com/companies/country/united-states) |
| 19 | [Immunovant IMVT · Health Care](https://funkfolio.com/stock/IMVT) | $6.9B | $33.21 | 0.21% down | 40% up | Price over the last month: up 20.2% | [United States](https://funkfolio.com/companies/country/united-states) |
| 20 | [ImmunityBio IBRX · Health Care](https://funkfolio.com/stock/IBRX) | $6.7B | $6.26 | 4.68% up | 185% up | Price over the last month: down 25.7% | [United States](https://funkfolio.com/companies/country/united-states) |
| 21 | [Kodiak Sciences KOD · Health Care](https://funkfolio.com/stock/KOD) | $6.3B | $96.80 | 3.90% down | 424% up | Price over the last month: up 6.0% | [United States](https://funkfolio.com/companies/country/united-states) |
| 22 | [Scholar Rock Holding SRRK · Health Care](https://funkfolio.com/stock/SRRK) | $5.5B | $45.08 | 1.21% up | 12% up | Price over the last month: up 12.0% | [United States](https://funkfolio.com/companies/country/united-states) |
| 23 | [Adaptive Biotechnologies ADPT · Health Care](https://funkfolio.com/stock/ADPT) | $4.6B | $28.49 | 2.22% up | 103% up | Price over the last month: up 19.0% | [United States](https://funkfolio.com/companies/country/united-states) |
| 24 | [CRISPR Therapeutics CRSP · Health Care](https://funkfolio.com/stock/CRSP) | $3.9B | $40.15 | 0.54% down | 24% down | Price over the last month: down 19.8% | [Switzerland](https://funkfolio.com/companies/country/switzerland) |

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration.

### Questions and answers

**Which biotech rank first by market value?**

Amgen ($247.7B), Gilead Sciences ($211.2B) and Moderna ($83.7B) are the top three of the 24 biotech ranked by market value as of 18 Nov 2026, 09:32 UTC.

**How many biotech are in this ranking?**

24 are ranked by market value.

**What are these biotech worth together?**

The 24 biotech ranked by market value have a combined market value of $848.9B as of 18 Nov 2026, 09:32 UTC.

**What does ranking by market value measure?**

What the stock market values the whole company at: its share price times the number of its shares.

### Learn how this ranking works

[All markets guides →](https://funkfolio.com/learn/markets)

- [What market capitalization is, and what it is not](https://funkfolio.com/learn/markets/market-capitalization)

  Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- [Market cap vs enterprise value: what is the difference?](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

  Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- [How an ETF's size is measured: AUM, NAV and creation units](https://funkfolio.com/learn/markets/etf-assets-under-management)

  An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.

### Cite this page

Funkfolio, “Largest biotech by market cap”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech

Underlying data: Yahoo Finance; SEC EDGAR.
